??? Extended Summary: "U.S. Open at Oakmont Picks and Predictions"
Introduction & Frustration with Canadian Open (0:16 – 5:00)
Will Doctor begins with enthusiasm for the U.S. Open at Oakmont, marking its tenth time hosting—more than any other venue. He immediately reflects on his disastrous picks from the prior RBC Canadian Open, admitting to a 5.8-unit loss and labeling the Osprey Valley course “a disgrace.” He laments that even his chosen players, including Clanton, Woodland, and Van Rooyen, didn’t make the cut and appeared disengaged. Only Sam Burns’ top-20 finish offered redemption. He praises Ryan Fox’s historic win as the first Kiwi to claim the Canadian Open since 1968 and highlights his back-to-back playoff victories.
? Oakmont Legacy & Historical Wins (5:00 – 12:00)
Doctor reveres Oakmont as the "Mount Rushmore" of U.S. Open venues. He recounts major moments: Tommy Armour's 1927 win, Sam Parks Jr.'s surprise 1935 title, and Ben Hogan's 1953 triumph in his legendary three-major season. The 1962 U.S. Open marked Jack Nicklaus’ first professional win over Arnold Palmer—whom he defeated in a playoff. Johnny Miller’s 63 in 1973, still hailed by Doctor as the greatest round in U.S. Open history, gets detailed praise. Oakmont has consistently produced champions, from Larry Nelson in 1983 to Dustin Johnson in 2016, all enduring its relentless difficulty.
Outright Favorites: Scheffler & DeChambeau (12:00 – 19:30)
Scottie Scheffler is the primary outright pick at +350. Citing three wins in his last four starts, including dominating performances at the Nelson (+8), PGA (+5), and Jack’s Place (+4), Doctor emphasizes Scheffler’s maturity since missing the cut at Oakmont in 2016 by one stroke. Bryson DeChambeau is backed at 14-1 due to strong recent form, despite erratic driving. DeChambeau believes Oakmont is “the toughest test in the world.” Doctor praises his improved iron play and short game, fueled by new LA Golf irons.
Matchup & Fade Picks: Rory, Rahm, Xander, Morikawa (19:30 – 24:00)
Doctor fades Rory McIlroy due to a missed cut and erratic performance at the Canadian Open. Rory admitted to lacking motivation and wanting to pursue tennis. John Rahm is chosen in a head-to-head bet against Rory at -133, thanks to his all-around form and low amateur finish at Oakmont in 2016. Rahm’s putting has dipped, but Doctor remains confident. Xander Schauffele and Collin Morikawa are both passed over—Xander for season-long driving issues and Morikawa for poor scrambling, having lost shots around the greens in five of his last six tournaments.
Nationality Picks: Åberg and Matsuyama (24:00 – 27:30)
Doctor chooses Ludwig Åberg to top the Nordic leaderboard at +180. With strong metrics in ball striking and putting, Åberg outshines his Nordic peers—especially Joachim Lagerlund, who had a rare strong week. Hideki Matsuyama is tipped to top the Japanese contingent at even money. Despite minor driving issues, his two top-six U.S. Open finishes in the last three years and 10 PGA Tour wins make him a favorite over less experienced compatriots.
Outrights & Longshots (27:30 – 32:00)
Doctor reaffirms Scheffler, DeChambeau, and an older Brooks Koepka ticket at 18-1 (now 55-1 and faded due to poor form). New picks include Keegan Bradley at 100-1, praised for his precision off the tee, strong iron play, and recent resurgence—including top-10 finishes at the PGA and Memorial. He’s positioned to possibly captain the Ryder Cup team as a playing member. Cam Young, added at 150-1, earned respect for consistent top finishes, elite putting, and surviving a tough U.S. Open playoff qualification.
Lineups & Predictions (32:00 – 36:20)
DraftKings lineup: Rahm, Åberg, Spieth, Bradley, Young, and Leishman. PGA Tour.com lineup: Scheffler (captain), Bradley, DeChambeau, Young, with Åberg and Leishman on the bench. Doctor forecasts a winning score of -3, assuming moderate rain. His best bet: Cam Young to finish top 28 at +320.
Conclusion
Will Doctor delivers a passionate, statistics-backed guide to Oakmont’s U.S. Open, blending historical reverence, sharp betting strategy, and candid critiques. His insight bridges past legacy and present form, spotlighting both favorites and sleepers with data-driven confidence.